Helpdesk

Sales contact

Home > Televisit

Televisit

Article

3 considerations to take into account when setting up an eCOA clinical trial

In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains crucial to maintain high-quality electronic Clinical Outcome Assessments (eCOA) data. This is paramount to ensure...

Infographic

Televisits for more engaging clinical trials

Televisit

If it is important to enable televisits for DCT trials, embedding the feature directly into the eCOA app brings multiple...

Article

Televisits in clinical trials: Why integrate a telemedecine feature in your eCOA trials?

Televisit

With clinical trials digitalization and decentralization comes the possibility for patients to complete several of their clinical study procedures remotely,...

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

Tackling the specificities of NASH/MASH clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA